Gallacher Capital Management LLC

Position in JNJ — Johnson & Johnson

CIK 1960749 LONE TREE, CO

Position in JNJ

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$440,130

-$160,459 QoQ

Shares Held

1,733

-29.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#3,814

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gallacher Capital Management LLC holds $3,790,927 across 9 Drug Manufacturers - General names. JNJ ranks #4 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	532	$638,096
2	NVS	Novartis AG	3,514	$550,714
3	NVO	Novo Nordisk A S	11,461	$549,440
4	JNJ	Johnson & Johnson This page	1,733	$440,130
5	GSK	GSK plc	8,312	$435,715
6	AZN	Astrazeneca PLC	2,120	$401,994
7	AMGN	Amgen Inc	797	$288,609
8	SNY	Sanofi	6,375	$271,957

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$440,130	1,733	-29.5%	Shares	Sole	2026-07-17
2026-03-31	$600,589	2,457	0.0%	Shares	Sole	2026-05-06
2025-12-31	$508,476	2,457	0.0%	Shares	Sole	2026-02-03
2025-09-30	$455,576	2,457	0.0%	Shares	Sole	2025-11-05
2025-06-30	$375,306	2,457	-0.0%	Shares	Sole	2025-07-08
2025-03-31	$407,634	2,458	-0.3%	Shares	Sole	2025-05-05
2024-12-31	$356,632	2,466	+0.2%	Shares	Sole	2025-02-10
2024-09-30	$398,667	2,460	-4.7%	Shares	Sole	2024-11-12
2024-06-30	$377,238	2,581	-16.6%	Shares	Sole	2024-08-06
2024-03-31	$489,439	3,094	-13.3%	Shares	Sole	2024-05-06
2023-12-31	$559,561	3,570	+39.0%	Shares	Sole	2024-02-06
2023-09-30	$400,121	2,569	+0.2%	Shares	Sole	2023-11-13
2023-06-30	$424,558	2,565	+0.2%	Shares	Sole	2023-08-11
2023-03-31	$396,800	2,560	-1.4%	Shares	Sole	2023-05-12
2022-12-31	$458,760	2,597	—	Shares	Sole	2023-01-17
No filing history on record for this holder in this stock.